Soluble ST2: a new and promising activity marker in ulcerative colitis.
about
The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases.Biomarkers of inflammatory bowel disease.Role of IL-33 and its receptor in T cell-mediated autoimmune diseasesThe alarmin IL-33 promotes regulatory T-cell function in the intestineInflammation, Innate Immunity, and the Intestinal Stromal Cell Niche: Opportunities and Challenges.Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolutionST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host disease.Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33.The role of IL-33 in gut mucosal inflammation.The Presage(®) ST2 Assay: analytical considerations and clinical applications for a high-sensitivity assay for measurement of soluble ST2.Emerging role of interleukin-33 in autoimmune diseases.Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy.A functional IL1RL1 variant regulates corticosteroid-induced sST2 expression in ulcerative colitisIL-33 Signaling in Lung InjuryNoninvasive Markers of Disease Activity in Inflammatory Bowel Disease.Innate immunity modulation by the IL-33/ST2 system in intestinal mucosaImmunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection.
P2860
Q33593742-E73C57E6-2586-4DB0-B4A7-DD14FD4620BFQ33746983-1C1BE592-B225-497C-B11C-63305CCE4B21Q33854499-5CEDDB70-C248-48B6-ABA3-3C0AEB92590FQ35116283-DD0E3619-B932-447A-A226-5D5769970FB9Q35754092-5ECD0482-ED1C-40F4-B849-3FAD74070398Q36114510-095119ED-27EF-477A-9AD6-949B7D62C609Q36424657-56D902DF-4213-4AAD-983C-638385B17E48Q36744984-AFABF4E0-1AA3-47E4-BA1B-E3C32CB0B245Q36914110-8402C860-5036-4381-8F1F-EA0369FB1253Q38068933-CAF5540A-C5B8-44F8-9221-0703D89BDAAFQ38151715-3294C39D-8414-4E8E-BFA8-36DE793DB2EEQ38492052-2E961414-C472-4F4C-98A5-2376E84DC1ADQ38599081-90F6FCF7-C79C-455A-B291-0AA83EA0CD8EQ38930643-9BE6FF6B-49E4-49AB-A369-41FD187381E5Q39464033-D9FCBD35-D456-4291-9154-D7BD40876A42Q41479687-B1CAB96B-8643-4EA1-A503-20BF28860A72Q41524859-D889475E-B025-43D5-884F-4D3B24E01CA5
P2860
Soluble ST2: a new and promising activity marker in ulcerative colitis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Soluble ST2: a new and promising activity marker in ulcerative colitis.
@ast
Soluble ST2: a new and promising activity marker in ulcerative colitis.
@en
Soluble ST2: a new and promising activity marker in ulcerative colitis.
@nl
type
label
Soluble ST2: a new and promising activity marker in ulcerative colitis.
@ast
Soluble ST2: a new and promising activity marker in ulcerative colitis.
@en
Soluble ST2: a new and promising activity marker in ulcerative colitis.
@nl
prefLabel
Soluble ST2: a new and promising activity marker in ulcerative colitis.
@ast
Soluble ST2: a new and promising activity marker in ulcerative colitis.
@en
Soluble ST2: a new and promising activity marker in ulcerative colitis.
@nl
P2093
P2860
P356
P1476
Soluble ST2: a new and promising activity marker in ulcerative colitis
@en
P2093
Cristóbal Suazo
David Díaz-Jiménez
Enzo Candia
Lucía E Núñez
Manuel Alvarez-Lobos
Marcela A Hermoso
María-Julieta González
P2860
P304
P356
10.3748/WJG.V17.I17.2181
P407
P577
2011-05-01T00:00:00Z